Results 151 to 160 of about 20,565 (193)

Microbial Fermentation Reduces Xerostomia-Related 5-Demethylnobiletin in Aurantii Fructus: A Chromatographic and Pharmacological Evaluation. [PDF]

Biomed Chromatogr
Xie Y, Liu M, Liu M, Zhang T, Wang C, Wang Y, Zhang J.   +6 more
europepmc   +1 more source

4‐Octyl Itaconate Attenuates Age‐Induced Parotid Gland Dysfunction Through the Suppression of Fibrosis and Lipid Deposition by AMPKα/PPARα and the Inhibition of Oxidative Stress via the AMPKα/Nrf2 Signaling Pathway

The FASEB Journal, Volume 40, Issue 19, 15 October 2026.
4‐Octyl itaconate (4‐OI) attenuates age‐induced parotid gland dysfunction through the suppression of fibrosis and lipid deposition by AMPKα/PPARα and the inhibition of oxidative stress via the AMPKα/Nrf2 signaling pathway. 4‐OI activates AMPKα, which in turn stimulates both the PPARα and Nrf2 pathways. Activation of PPARα enhances FAO and reduces lipid
Yun Chen, Tianyuan Gong, Zhongyan Shan, Jing Lai, Yiming Xu, Han Zhao, Lilei Zhu   +6 more
wiley   +1 more source

Development and Initial Psychometric Validation of the Multidimensional Menopausal Burden Questionnaire (MMBQ-44) in a Sample of Romanian Women. [PDF]

Diagnostics (Basel)
Dragomir AC, Buzatu AR, Marin RC, Moleriu RD, Muntean C, Piroș T, Crintea IN, Alexa AA, Marcu A, Dinuți M.   +9 more
europepmc   +1 more source

The Lupus Damage Index Revision Program: Results From the Item Generation and Reduction Phases

Arthritis Care &Research, Volume 78, Issue 10, Page 1449-1466, October 2026.
Objective A data‐driven and expert/patient consensus‐based project to develop a revised Systemic Lupus International Collaborating Clinics (SLICC)/American College of Rheumatology (ACR) Damage Index (SDI) is under way supported by SLICC, ACR, and the Lupus Foundation of America. Our objective is to report the item generation and reduction phase results
Burak Kundakci, Megan R. W. Barber, Ann E. Clarke, Sindhu R. Johnson, Anselm Mak, Hermine I. Brunner, Murat Inanc, Rosalind Ramsey‐Goldman, Guillermo Ruiz‐Irastorza, Ellen M. Ginzler, John G. Hanly, Alexandra Legge, Cynthia Aranow, Laurent Arnaud, Nathalie Costedoat‐Chalumeau, Dafna D. Gladman, Søren Jacobsen, Michelle Petri, Clovis A. Silva, Évelyne Vinet, Alexandre E. Voskuyl, SDI Revision Literature Review Groups, SDI Revision Delphi Panel, SDI Revision Item Reduction Committee, SDI Revision Clinical Domain Groups, Ian N. Bruce   +25 more
wiley   +1 more source

Halitosis: A Prospective Cohort Study Comparing Periodontal Debridement with Tongue Cleaning, Denture Biofilm Management, and Restorative Maintenance. [PDF]

Dent J (Basel)
Boloș A, Boloș OC, Maghet E, Bita RG, Briceag R, Bumbu BA, Brad S.   +6 more
europepmc   +1 more source

The Role of Dysphagia in Depression, Anxiety, and Symptom Clusters Among Nasopharyngeal Carcinoma Survivors After Intensity‐Modulated Radiotherapy: A Latent Profile and Mediation Analysis Based on a Cross‐Sectional Study

Cancer Medicine, Volume 15, Issue 10, October 2026.
ABSTRACT Objective To identify distinct dysphagia profiles among nasopharyngeal carcinoma (NPC) survivors and to examine the mediating roles of depression and anxiety in the relationship between these profiles and broader symptom clusters. This study hypothesized that subgroup membership would have differential effects on symptom clusters through ...
Hui Zhao, Yongjiao Kang, Jiajie Xu, Yanling Wen, Wen Hu, Yuying Fan, Yan He   +6 more
wiley   +1 more source

Intraoral Condition as a Risk Factor for Dysphagia in Non-Hospitalized Older People: An Updated Systematic Review. [PDF]

Spec Care Dentist
Rezeki A, Kusdhany LS, Indrasari M, Soejono CH.   +3 more
europepmc   +1 more source

Long‐Term Patient‐Reported Outcomes and Dosimetric Predictors of Quality of Life After Curative‐Intent Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma: A Cross‐Sectional Study

Cancer Reports, Volume 9, Issue 10, October 2026.
ABSTRACT Background Radiation therapy (RT) is central to curative treatment for oropharyngeal squamous cell carcinoma (OPSCC) but may cause late side effects that can adversely impact quality of life (QOL). As OPSCC treatment becomes more personalised, clinically meaningful QOL endpoints and their predictors are increasingly important.
Anna Lawless, Dasantha Jayamanne, Lisa Parker, Esther Duruchukwu, Paula Macleod, Venkatesha Venkatesha, Christopher Brown, Alexander Guminski, Adrian Lee, Michael Back, Thomas Eade, Sarah Bergamin   +11 more
wiley   +1 more source